Ramin M Jebraili Md is categorized under Orthopedic Doctors and Physicians in Washington, DC and active since 1996.
Ramin M Jebraili Md was established in 1996, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Orthopedic Doctors and Physicians business, which does work in the B2C market, and is classified as a Orthopedic Doctors and Physicians, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Ramin M Jebraili at the company’s single location by writing to 3 Washington Circle Nw # 309, Washington, District of Columbia DC 20037 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Ramin M Jebraili Md |
| Contact Person: | Ramin M Jebraili |
| Address: | 3 Washington Circle Nw # 309, Washington, District of Columbia 20037 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1996 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Orthopedic Doctors and Physicians |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Ramin M Jebraili Md was started in 1996 to provide professional Orthopedic Doctors and Physicians under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Ramin M Jebraili for inquiries that concern Ramin M Jebraili Md by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Ramin M Jebraili Md can be found at the coordinates as well as the street address 3 Washington Circle Nw # 309 in Washington, District of Columbia 20037.
For its online presence, you may visit Ramin M Jebraili Md’s website at and engage with its social media outlets through on Twitter and on Facebook.